These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24666740)

  • 1. Mechanical factors affecting nebulized albuterol aerosol particle sizes for asthma drug delivery.
    Itoga NK; Kinoshita CK; Masutani SM; Yamamoto LG
    Am J Emerg Med; 2014 Jun; 32(6):569-72. PubMed ID: 24666740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicochemical aspects and efficiency of albuterol nebulization: comparison of three aerosol types in an in vitro pediatric model.
    Sidler-Moix AL; Di Paolo ER; Dolci U; Berger-Gryllaki M; Cotting J; Pannatier A
    Respir Care; 2015 Jan; 60(1):38-46. PubMed ID: 25516995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albuterol delivery in an in vitro pediatric ventilator lung model: comparison of jet, ultrasonic, and mesh nebulizers.
    Sidler-Moix AL; Dolci U; Berger-Gryllaki M; Pannatier A; Cotting J; Di Paolo ER
    Pediatr Crit Care Med; 2013 Feb; 14(2):e98-102. PubMed ID: 23287904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of flow pattern, device and formulation on particle size distribution of nebulized aerosol.
    Hu J; Zhang R; Beng H; Deng L; Ke Q; Tan W
    Int J Pharm; 2019 Apr; 560():35-46. PubMed ID: 30664994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of aerosol output from various nebulizer/compressor combinations.
    Reisner C; Katial RK; Bartelson BB; Buchmeir A; Rosenwasser LJ; Nelson HS
    Ann Allergy Asthma Immunol; 2001 May; 86(5):566-74. PubMed ID: 11379809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of nebulizer type, position, and bias flow on aerosol drug delivery in simulated pediatric and adult lung models during mechanical ventilation.
    Ari A; Atalay OT; Harwood R; Sheard MM; Aljamhan EA; Fink JB
    Respir Care; 2010 Jul; 55(7):845-51. PubMed ID: 20587095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.
    Elhissi AM; Karnam KK; Danesh-Azari MR; Gill HS; Taylor KM
    J Pharm Pharmacol; 2006 Jul; 58(7):887-94. PubMed ID: 16805947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two methods of delivering continuously nebulized albuterol.
    Kelly HW; Keim KA; McWilliams BC
    Ann Pharmacother; 2003 Jan; 37(1):23-6. PubMed ID: 12503928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal duration of nebulized albuterol therapy.
    Malone RA; Hollie MC; Glynn-Barnhart A; Nelson HS
    Chest; 1993 Oct; 104(4):1114-8. PubMed ID: 8404177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The choice of jet nebulizer, nebulizing flow, and addition of albuterol affects the output of tobramycin aerosols.
    Coates AL; MacNeish CF; Meisner D; Kelemen S; Thibert R; MacDonald J; Vadas E
    Chest; 1997 May; 111(5):1206-12. PubMed ID: 9149571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhalation and deposition of nebulized sodium cromoglycate in two different particle size distributions in children with asthma.
    Nerbrink OL; Lindström M; Meurling L; Svartengren M
    Pediatr Pulmonol; 2002 Nov; 34(5):351-60. PubMed ID: 12357479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.
    Elhissi AM; Faizi M; Naji WF; Gill HS; Taylor KM
    Int J Pharm; 2007 Apr; 334(1-2):62-70. PubMed ID: 17123757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication nebulizer performance. Effects of diluent volume, nebulizer flow, and nebulizer brand.
    Hess D; Fisher D; Williams P; Pooler S; Kacmarek RM
    Chest; 1996 Aug; 110(2):498-505. PubMed ID: 8697857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of methods to measure aerosols generated by a vibrating mesh nebulizer.
    Waldrep JC; Berlinski A; Dhand R
    J Aerosol Med; 2007; 20(3):310-9. PubMed ID: 17894537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous nebulization therapy for asthma with aerosols of beta2 agonists.
    Raabe OG; Wong TM; Wong GB; Roxburgh JW; Piper SD; Lee JI
    Ann Allergy Asthma Immunol; 1998 Jun; 80(6):499-508. PubMed ID: 9647274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal evaluation of compressor/nebulizer performance.
    Awad S; Williams DK; Berlinski A
    Respir Care; 2014 Jul; 59(7):1053-61. PubMed ID: 24149670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of Heliox on the output and particle-size distribution of salbutamol using jet and vibrating mesh nebulizers.
    O'Callaghan C; White J; Jackson J; Crosby D; Dougill B; Bland H
    J Aerosol Med; 2007; 20(4):434-44. PubMed ID: 18158716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring nebulizer output. Aerosol production vs gravimetric analysis.
    Tandon R; McPeck M; Smaldone GC
    Chest; 1997 May; 111(5):1361-5. PubMed ID: 9149595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An in vitro analysis of the output of salbutamol from different nebulizers.
    Barry PW; O'Callaghan C
    Eur Respir J; 1999 May; 13(5):1164-9. PubMed ID: 10414421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of nebulized particle size distribution with Malvern laser diffraction analyzer versus Andersen cascade impactor and low-flow Marple personal cascade impactor.
    Kwong WT; Ho SL; Coates AL
    J Aerosol Med; 2000; 13(4):303-14. PubMed ID: 11262437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.